Aandelen in “Gezondheidstechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Gezondheidstechnologie”

30/04 · BD to Present at Bank of America Securities Health Care Conference · Persbericht

30/04 · BD to Present at Bank of America Securities Health Care Conference · Persbericht

30/04 · Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference · Persbericht

30/04 · Accuray Reports Fiscal 2025 Third Quarter Financial Results · Persbericht

30/04 · REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights · Persbericht

30/04 · 10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference · Persbericht

30/04 · DBV Technologies Reports First Quarter 2025 Financial Results · Persbericht

30/04 · Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025 · Persbericht

30/04 · Combined General Meeting of May 22, 2025 - Availability of the preparatory documents · Persbericht

30/04 · Press Release: Annual General Meeting of April 30, 2025 · Persbericht

30/04 · EssilorLuxottica: EssilorLuxottica 2025 Annual Shareholders’ Meeting · Persbericht

30/04 · Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting · Persbericht

30/04 · Zynex, Inc. (ZYXI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

30/04 · Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director · Persbericht

30/04 · Mise à disposition du rapport financier annuel 2024 · Persbericht

30/04 · Beursagenda: Belgische bedrijven · Trends (€)

(ABM FN) Hieronder volgen de belangrijkste items op de financiële agenda voor België tot en met donderdag 8 mei 2025:DONDERDAG 1 MEI 202509:00 Euronext Brussel gesloten op Dag van de ArbeidVRIJDAG 2 MEI 202509:00 WDP - Ex-dividend00:00...

30/04 · Perrigo Announces Quarterly Dividend · Persbericht

30/04 · Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 · Persbericht

30/04 · Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG) · Persbericht

30/04 · INOVIO to Present at Upcoming Scientific and Investor Conferences · Persbericht

30/04 · BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025 · Persbericht

Mijn selecties